Store
The Market for In Vitro Diagnostic (IVD) Tests in Latin America, 2021
Publication Date: June 29, 2021
Tags: Coagulation, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Latin America, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 195
SKU: 21-025
Latin America (LATAM) presents significant expansion opportunities for in vitro diagnostic (IVD) manufacturers. Kalorama Information’s latest report focuses on the market for reagents and instruments across key LATAM countries, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, and Venezuela. Additionally, the report covers Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay to provide a comprehensive regional overview.
Report Highlights:
- Market Potential: Combined, these countries represent a population of 636 million, making LATAM a substantial potential market for IVD products. Brazil and Mexico, the two largest countries by population, account for over half of LATAM’s total population and have been primary focuses for IVD suppliers. Economic improvements in other countries like Chile, Colombia, and Peru also present new growth opportunities.
Segments Analyzed:
The report provides an in-depth analysis of various segments within the IVD market, including:
- Clinical Chemistry: Substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC).
- Critical Care: Blood gas and electrolytes, including rapid tests.
- Urinalysis: Manual, semi-automated, and automated systems, including urine strips and urine sediment reagents.
- Microbiology Immunoassays: HIV, Hepatitis, ToRCH, Influenza, Syphilis, and other infectious diseases agents (excluding blood bank tests).
- Immunoassay (non-microbiology): Hormones, tumor markers, bone markers, oncology markers, autoimmunity, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, non-POC drugs of abuse testing, and therapeutic drug monitoring.
- Cardiac Markers: Non-POC cardiac markers such as Troponine, BNP, CK-MB, Homocystein, Myoglobin.
- Blood Banking: Immunotyping and infectious diseases screening.
- Microbiology: Manual and automated tests, culture media, latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma.
- Molecular Microbiology: HIV, Hepatitis, STDs, MRSA, MTB, Sepsis, EBV, CMV, Respiratory Panel, and other infectious diseases agents, including multiplex NAT.
- Point of Care (POC): All POC tests for cardiology, toxicology, coagulation, infectious diseases (excluding POC glucose testing).
- Glucose Testing: Diabetes glucose monitoring strips.
- Primary Staining Histology: PAP, HE, and other primary stains.
- Advanced Staining Histology: IHC, ISH, FISH, primary and secondary antibodies.
- Hematology: Manual, semi-automated, and automated (CBC and 5 Diff).
- Coagulation: PT, APTT, coagulation factors, Fibrinogen, FDP, Lupus Anticoagulant, and other analytes from the thrombosis and hemostasis pathway.
- Flow Cytometry: Manual, semi-automated, and automated flow cytometry for CD4/CD8 (AIDS), leukemia, lymphoma.
- Other Molecular: Oncology, hemato-oncology, hereditary diseases, hemostasis, and hematology diseases.
For further details and to purchase directly, please contact us.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
- OVERVIEW
- Table 1-1 Population and GDP in Seven Leading IVD Latin American Countries
- SIZE OF THE MARKET AND GROWTH
- Figure 1-1: IVD Market in Latin America, 2020-2025
- LATIN AMERICAN IVD MARKET BY COUNTRY
- Figure 1-2: Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, other LATAM), % 2020
- GROWTH OF IVD MARKET IN LATIN AMERICA BY COUNTRY, CAGR 2020 TO 2025
- Figure 1-3: Average Growth of Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, other LATAM), CAGR 2020 to 2025
- IVD COMPANY MARKET SHARE IN LATIN AMERICA
- Figure 1-4: IVD Market Share in Latin America, by Company, 2020
- SEGMENTS DEFINITION
- MARKET LEADERSHIP IN IVD SEGMENTS
- Table 1-2: Latin American Market Leaders in Selected Segments (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Microbiology, Molecular Microbiology, Histology, Hematology, Coagulation, Flow Cytometry)
- RESEARCH METHODOLOGY
CHAPTER 2: ARGENTINA
- OVERVIEW AND DEMOGRAPHICS
- Table 2-1: Key Facts, Argentina (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Argentina
- Table 2-1: Health System and Indicators, Argentina (Physician Density, Hospital Bed Density, Hospital Total, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 2-2: Economic Profile, Argentina (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Argentina
- IVD MARKET ANALYSIS – ARGENTINA
- Total Market Size
- Table 2-3: Argentinian IVD Market by Sector, 2020-2025 (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) in $US thousands
- IVD Market in Argentina by Segment
- Figure 2-1: Argentinian IVD Market Distribution by Sector (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 2-2: Average Growth of IVD Markets in Argentina (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Argentina
- Figure 2-3: Clinical Chemistry Market in Argentina by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-4: Clinical Chemistry Market in Argentina, Market Participant Share (%), 2020
- General Chemistry Market in Argentina
- Critical Care Market in Argentina
- Urinalysis Market in Argentina
- Immunoassay Market in Argentina
- Figure 2-5: Immunoassay Market in Argentina by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-6: Immunoassay Market in Argentina, Market Participant Share (%), 2020
- Microbiology Immunoassay Market in Argentina
- Cardiac Markers (non-POC) Market in Argentina
- Non-Microbiology Immunoassay Market in Argentina
- Blood Banking Market in Argentina
- Microbiology Market in Argentina
- Figure 2-7: Microbiology Market in Argentina by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-8: Microbiology Market in Argentina, Market Participant Share (%), 2020
- ID/AST Market in Argentina
- Molecular Microbiology and Nucleic Acid Test Market in Argentina
- POC Market in Argentina
- Figure 2-8: POC Market in Argentina by Segment (glucose, other), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-9: POC Market in Argentina, Market Participant Share (%), 2020
- POC Glucose Testing Market in Argentina
- Histology Market in Argentina
- Figure 2-10: Histology Market in Argentina, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Argentina
- Coagulation Market in Argentina
- Flow Cytometry Market in Argentina
- Non-infectious Disease Molecular Market in Argentina
- Market Participants
- Abbott Diagnostics
- Becton Dickinson Argentina
- Bioars SA
- Biodiagnostico SA
- bioMérieux
- Bio-Rad Laboratories, Inc.
- Gematec SRL
- Grifols Argentina SA
- LifeScan Argentina
- Rochem Biocare Argentina S.A.
- Productos Roche SA
- Siemens Healthcare S.A. Argentina
- Wiener Lab
- WM Argentina
- Market Share
- Table 2-4: IVD Market Share by Company, Argentina (%), 2020
- Figure 2-11: IVD Market Argentina, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 3: BRAZIL
- OVERVIEW AND DEMOGRAPHICS
- Table 3-1: Key Facts, Brazil (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Brazil
- Medical Facilities
- Table 3-2: Health System and Indicators, Brazil (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 3-3: Economic Profile, Brazil (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Brazil
- IVD MARKET ANALYSIS – BRAZIL
- Total Market Size
- Table 3-4: Brazil IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Brazil by Segment
- Figure 3-1: Brazil IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 3-2: Average Growth of IVD Markets in Brazil (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Brazil
- Figure 3-3: Clinical Chemistry Market in Brazil by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-4: Clinical Chemistry Market in Brazil, Market Participant Share (%), 2020
- General Chemistry Market in Brazil
- Critical Care Market in Brazil
- Urinalysis Market in Brazil
- Immunoassay Market in Brazil
- Figure 3-5: Immunoassay Market in Brazil by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-6: Immunoassay Market in Brazil, Market Participant Share (%), 2020
- Microbiology Immunoassay Market in Brazil
- Immunoassay (non-Microbiology) Market in Brazil
- Cardiac Marker (non-POC) Market in Brazil
- Blood Banking Market in Brazil
- Microbiology Market in Brazil
- Figure 3-7: Microbiology Market in Brazil by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-8: Microbiology Market in Brazil, Market Participant Share (%), 2020
- Molecular Microbiology Market in Brazil
- POC Market in Brazil
- Figure 3-9: POC Market in Brazil by Segment (glucose and other), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-10: POC Market in Brazil, Market Participant Share (%), 2020
- Histology Market in Brazil
- Figure 3-11: Histology Market in Brazil, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 $US thousands
- Hematology Market in Brazil
- Coagulation Market in Brazil
- Flow Cytometry Market in Brazil
- Non-infectious Disease Molecular Market in Brazil
- Market Participants
- Abbott Laboratorios do Brazil Ltda.
- Becton Dickinson
- bioMérieux Brazil SA
- Bio-Rad Laboratorios Brasil Ltda
- Danaher – Beckman Coulter
- DiaSorin Ltda.
- HORIBA ABX
- Labtest
- Ortho-Clinical Diagnostics
- LifeScan Brazil
- Qiagen
- Roche
- Siemens Healthcare Diagnostics SA
- Sysmex do Brasil Industria e Comercio Ltda.
- WAMA Diagnostica
- Wiener Laboratories SAIC/Labinbraz
- Market Share
- Table 3-5: IVD Market Share by Company, Brazil, 2020
- Figure 3-12: IVD Market Brazil, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 4: CHILE
- OVERVIEW AND DEMOGRAPHICS
- Table 4-1: Key Facts, Chile (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Chile
- Table 4-2: Health System and Indicators, Chile (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 4-3: Economic Profile, Chile (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Chile
- IVD MARKET ANALYSIS – CHILE
- Total Market Size
- Table 4-4: Chile IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 in $US thousands
- Figure 4-1: Chile IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 4-2: Average Growth of IVD Markets in Chile (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Chile
- Figure 4-3: Clinical Chemistry Market in Chile by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 4-4: Clinical Chemistry Market in Chile, Market Participant Share (%), 2020
- Urinalysis Market in Chile
- Immunoassay Market in Chile
- Figure 4-5: Immunoassay Market in Chile by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 4-6: Immunoassay Market in Chile, Market Participant Share (%), 2020
- Microbiology Immunoassay Market in Chile
- Immunoassay (non-Microbiology) Market in Chile
- Cardiac Marker (non-POC) Market in Chile
- Blood Banking Market in Chile
- Microbiology Market in Chile
- Molecular Microbiology and NAT Market in Chile
- POC Market in Chile
- Figure 4-7: POC Market in Chile by Segment (glucose, other), Estimate and Forecast, 2020-2025 $US thousands
- Glucose Testing Market in Chile
- Histology Market in Chile
- Figure 4-8: Histology Market in Chile, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 $US thousands
- Hematology Market in Chile
- Coagulation Market in Chile
- Flow Cytometry Market in Chile
- Non-infectious Disease Molecular Market in Chile
- Market Participants
- Abbott Diagnostics
- BD Chile
- bioMérieux Chile SA
- Galenica
- Grifols Chile S.A.
- GrupoBios Chile
- LifeScan Chile
- Roche
- Siemens Healthcare Medical Equipment SPA
- Tecnigen S.A.
- Market Share
- Table 4-5: IVD Market Share by Company, Chile, 2020
- Figure 4-9: IVD Market Chile, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 5: COLOMBIA
- OVERVIEW AND DEMOGRAPHICS
- Table 5-1: Key Facts, Colombia (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Colombia
- Table 5-2: Health System and Indicators, Colombia (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 5-3: Economic Profile, Colombia (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Colombia
- IVD MARKET ANALYSIS – COLOMBIA
- Total Market Size
- Table 5-4: Colombia IVD Market by Sector, (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Colombia by Segment
- Figure 5-1: Colombia IVD Market Distribution by Sector (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 5-2: Average Growth of IVD Markets in Colombia (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Colombia
- Figure 5-3: Clinical Chemistry Market in Colombia by Segment (general chemistries, urinalysis), Estimate and Forecast, 2020-2025 $US thousands
- Figure 5-4: Clinical Chemistry Market in Colombia, Market Participant Share (%), 2020
- Immunoassay Market in Colombia
- Figure 5-5: Immunoassay Market in Colombia by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 5-6: Immunoassay Market in Colombia, Market Participant Share (%), 2020
- Microbiology Market in Colombia
- Figure 5-7: Microbiology Market in Colombia by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 5-8: Microbiology Market in Colombia, Market Participant Share (%), 2020
- Molecular Microbiology and NAT Market in Colombia
- POC Market in Colombia
- Figure 5-9: POC Market in Colombia by Segment (glucose, other), Estimate and Forecast, 2020-2025 $US thousands
- Histology Market in Colombia
- Figure 5-10: Histology Market in Colombia, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Colombia
- Coagulation Market in Colombia
- Flow Cytometry Market in Colombia
- Non-infectious Disease Molecular Market in Colombia
- Market Participants
- Abbott de Colombia SA
- Annar Diagnóstica Import SAS
- Becton Dickinson de Colombia Ltda
- bioMérieux Colombia SAS
- Biolore Ltda
- Bio-Rad Laboratories, Inc.
- Labcare de Colombia Ltda
- Laboratorio DAI de Colombia
- Quimiolab SAS
- Roche Diagnostics
- Rochem Biocare
- Siemens SA
- Werfen Colombia
- Market Share
- Table 5-5: IVD Market Share by Company, Colombia, 2020
- Figure 5-11: IVD Market Colombia, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 6: MEXICO
- OVERVIEW AND DEMOGRAPHICS
- Table 6-1: Key Facts, Mexico (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Mexico
- Table 6-2: Health System and Indicators, Mexico (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 6-3: Economic Profile, Mexico (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Mexico
- IVD MARKET ANALYSIS – MEXICO
- Total Market Size
- Table 6-4: Mexico IVD Market Distribution by Sector (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Mexico by Segment
- Figure 6-1: Mexico IVD Market Distribution by Sector (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 6-2: Average Growth of IVD Markets in Mexico (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Mexico
- Figure 6-3: Clinical Chemistry Market in Mexico by Segment (general chemistries, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 6-4: Clinical Chemistry Market in Mexico, Market Participant Share (%), 2020
- Immunoassay Market in Mexico
- Figure 6-5: Immunoassay Market in Mexico by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 6-6: Immunoassay Market in Mexico, Market Participant Share (%), 2020
- Immunoassay Microbiology Market in Mexico
- Immunoassay (non-Microbiology) Market in Mexico
- Microbiology Market in Mexico
- Figure 6-7: Microbiology Market in Mexico by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 6-8: Microbiology Market in Mexico, Market Participant Share (%), 2020
- POC Market in Mexico
- Figure 6-9: POC Market in Mexico by Segment (glucose, other), Estimate and Forecast, 2020-2025 ($US thousands)
- Histology Market in Mexico
- Figure 6-10: Histology Market in Mexico, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Mexico
- Coagulation Market in Mexico
- Flow Cytometry Market in Mexico
- Non-infectious Disease Molecular Market in Mexico
- Market Participants
- Abbott Diagnostics
- Becton Dickinson
- bioMérieux
- Bio-Rad SA
- Danaher
- DiaSorin S.p.A.
- LifeScan
- Roche
- Siemens Healthcare Diagnostics S. de RL de CV
- Thermo Fisher Scientific
- Market Share
- Table 6-5: IVD Market Share by Company, Mexico, 2020
- Figure 6-11: IVD Market Mexico, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 7: PERU
- OVERVIEW AND DEMOGRAPHICS
- Table 7-1: Key Facts, Peru (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Peru
- Table 7-2: Health System and Indicators, Peru (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 7-3: Economic Profile, Peru (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Peru
- IVD MARKET ANALYSIS – PERU
- Total Market Size
- Table 7-4: Peru IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Peru by Segment
- Figure 7-1: Peru IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 7-2: Average Growth of IVD Markets in Peru (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Peru
- Figure 7-3: Clinical Chemistry Market in Peru by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 7-4: Clinical Chemistry Market in Peru, Market Participant Share (%), 2020
- Immunoassay Market in Peru
- Figure 7-5: Immunoassay Market in Peru by Segment (infectious disease, cardiac markers, tumor markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 7-6: Immunoassay Market in Peru, Market Participant Share (%), 2020
- Immunoassay Microbiology Market in Peru
- Immunoassay (non-Microbiology) Market in Peru
- Blood Banking Market in Peru
- Microbiology Market in Peru
- Figure 7-7: Microbiology Market in Peru by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 7-8: Microbiology Market in Peru, Market Participant Share (%), 2020
- Molecular/NAT Microbiology Market in Peru
- POC Market in Peru
- Figure 7-9: POC Market in Peru by Segment (glucose, other), Estimate and Forecast, 2020-2025 ($US thousands)
- Histology Market in Peru
- Figure 7-10: Histology Market in Peru, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Peru
- Coagulation Market in Peru
- Flow Cytometry Market in Peru
- Non-infectious Disease Molecular Market in Peru
- Market Participants
- Abbott Laboratories SA
- Albis SA
- Beckman Coulter Peru – Danaher
- Becton Dickinson del Uruguay SA Peru Branch
- Belomed SRL
- Jampar Multiplest Internacional
- Labin Peru
- Roche Diagnostics
- Rochem Biocare
- Siemens Healthcare SAC
- Market Share
- Table 7-5: IVD Market Share by Company, Peru, 2020
- Figure 7-11: IVD Market Peru, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 8: VENEZUELA
- OVERVIEW AND DEMOGRAPHICS
- Table 8-1: Key Facts, Venezuela (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Venezuela
- Table 8-2: Health System and Indicators, Peru (Hospital Bed Density, Hospital Total, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 8-3: Economic Profile, Venezuela (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Venezuela
- IVD MARKET ANALYSIS – VENEZUELA
- Total Market Size
- Table 8-4: Venezuela IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Venezuela by Segment
- Figure 8-1: Venezuela IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 8-2: Average Growth of IVD Markets in Venezuela (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Venezuela
- Figure 8-3: Clinical Chemistry Market in Venezuela by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Immunoassay Market in Venezuela
- Figure 8-4: Immunoassay Market in Venezuela by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Microbiology Market in Venezuela
- Figure 8-5: Microbiology Market in Venezuela by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- POC Market in Venezuela
- Histology Market in Venezuela
- Hematology Market in Venezuela
- Coagulation Market in Venezuela
- Flow Cytometry Market in Venezuela
- Non-infectious Disease Molecular Market in Venezuela
- Market Participants
- Abbott Laboratories, CA
- Productos Roche SA – Roche Diagnostica
- Danaher
- Loginca
- Siemens
- Market Share
- Table 8-6: IVD Market Share by Company, Venezuela, 2020
- Figure 8-7: IVD Market Venezuela, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 9: LATIN AMERICA IVD MARKET SUMMARY
- DEMOGRAPHIC OVERVIEW
- Table 9-1: Demographics in Select Latin American Countries, 2020
- Figure 9-1: Population Comparison, Select Latin American Countries, 2020 (population in millions)
- Figure 9-2: Population Growth, Select Latin American Countries, 2020-2030 (%)
- Figure 9-3: Aging Population as a % of Total Population, Select Latin American Countries, 2020 (%)
- Figure 9-4: Life Expectancy at Birth by LATAM Country (Average 76 Years), 2020 (years)
- Table 9-2: Leading Causes of Death by Country, LATAM 2020
- BRIEF ECONOMIC OVERVIEW
- GDP in the Latin American Region
- Table 9-3: GDP in Select Latin American Countries, 2019
- Figure 9-5: GDP Comparison, Select Latin American Countries, 2019 (billions USD)
- Figure 9-6: GDP per Capita, Select Latin American Countries, 2019 (USD)
- Health Expenditure in Latin America
- Figure 9-7: Health Spending as a Percent of GDP by LATAM Country, 2019
- IVD Spending per Capita
- THE IVD MARKET IN LATIN AMERICA
- Table 9-4: IVD in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) 2020-2025 in $US thousands
- Figure 9-8: IVD in Latin America by Country, 2020-2025
- Figure 9-9: IVD in Latin America, Distribution of Sales by Select Country, 2020
- IVD Market Participation in Latin America
- Abbott
- Danaher
- Becton Dickinson
- bioMérieux
- Roche
- Siemens
- Figure 9-10: IVD Market Share by Participant, LATAM, 2020
- Conclusions, Recommendations and Market Attractiveness
- Table 9-5: IVD Attractiveness by LATAM Country, 2020-2025
- Figure 9-11: IVD Market Attractiveness by LATAM County, 2020-2025
Related products
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
November 29, 2023
In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…
$5,000.00 – $7,500.00
In Vitro Diagnostic (IVD) Procedure Volumes, 2023-2028
October 22, 2023
Gain invaluable insights into the global IVD market with Kalorama Information’s comprehensive report In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028. This analysis provides essential data on the number of IVD procedures, offering a gold standard for new entrants and existing marketers in the diagnostic products industry.
Â
…
$6,000.00 – $9,000.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
$5,000.00 – $7,875.00
